Literature DB >> 11920291

Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium.

Anne G Mosser1, Rebecca Brockman-Schneider, Svetlana Amineva, Lacinda Burchell, Julie B Sedgwick, William W Busse, James E Gern.   

Abstract

Rhinovirus (RV) infections can alter lower airway physiology and inflammation, yet the characteristics of RV replication in lower airway cells are incompletely understood. An RV serotype 16 (RV16)-specific monoclonal antibody was identified. Immunohistochemistry and an infectious center assay were used to quantitate the infectivity of RV16 in primary bronchial and adenoidal epithelial cells. The proportion of infectible epithelial cells increased with the inoculum but did not exceed 10%. Analysis of bronchial tissue samples infected ex vivo demonstrated a small subset of RV-infected cells in the epithelial layer. These data confirm previous reports that RV infects only a small subset of epithelial cells in upper airway tissues and indicate that lower airway epithelial cells have a similar susceptibility to RV infection. In confirming that RV can infect cells in the lower airway, these results suggest that lower airway dysfunction occurs through this mechanism in susceptible persons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920291     DOI: 10.1086/339339

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  76 in total

1.  Tumor necrosis factor family member LIGHT acts with IL-1β and TGF-β to promote airway remodeling during rhinovirus infection.

Authors:  A K Mehta; T Doherty; D Broide; M Croft
Journal:  Allergy       Date:  2018-03-01       Impact factor: 13.146

2.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways.

Authors:  Yin Chen; Edward Hamati; Pak-Kei Lee; Wai-Ming Lee; Shinichiro Wachi; David Schnurr; Shigeo Yagi; Gregory Dolganov; Homer Boushey; Pedro Avila; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

Review 3.  Asthma exacerbations. 2: aetiology.

Authors:  A M Singh; W W Busse
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

4.  Negative control of TLR3 signaling by TICAM1 down-regulation.

Authors:  Shasha Tao; Lingxiang Zhu; Pakkei Lee; Wai-ming Lee; Kenneth Knox; Jie Chen; Yuanpu Peter Di; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

5.  Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Authors:  Loren C Denlinger; Ron L Sorkness; Wai-Ming Lee; Michael D Evans; Michele J Wolff; Sameer K Mathur; Gina M Crisafi; Katie L Gaworski; Tressa E Pappas; Rose F Vrtis; Elizabeth A Kelly; James E Gern; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

6.  Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.

Authors:  Vasile Laza-Stanca; Luminita A Stanciu; Simon D Message; Michael R Edwards; James E Gern; Sebastian L Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages.

Authors:  Yutein Chung; Jun Young Hong; Jing Lei; Qiang Chen; J Kelley Bentley; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

8.  Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.

Authors:  Marrah E Lachowicz-Scroggins; Homer A Boushey; Walter E Finkbeiner; Jonathan H Widdicombe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

9.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

10.  Serial culture of murine primary airway epithelial cells and ex vivo replication of human rhinoviruses.

Authors:  Rebecca A Brockman-Schneider; Svetlana P Amineva; Maria V Bulat; James E Gern
Journal:  J Immunol Methods       Date:  2008-09-29       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.